首页> 外文期刊>Brazilian Journal of Medical and Biological Research >CCR5 genotype and plasma ?-chemokine concentration of Brazilian HIV-infected individuals
【24h】

CCR5 genotype and plasma ?-chemokine concentration of Brazilian HIV-infected individuals

机译:CCR5基因型和血浆? - 巴西艾滋病毒感染个体的浓度

获取原文
获取外文期刊封面目录资料

摘要

The 32-bp deletion in the HIV-1 co-receptor CCR5 confers a high degree of resistance to HIV-1 infection in homozygous individuals for the deleted allele and partial protection against HIV-1 during disease progression in heterozygotes. Natural ligands for CCR5, MIP-1alpha, MIP-1? and RANTES, have been shown to inhibit HIV replication in CD4+ T cells. In the present study, we examined the CCR5 genotype by PCR and the plasma levels of RANTES and MIP-1alpha by ELISA among blood donors (N = 26) and among HIV-1-infected individuals (N = 129). The control group consisted of healthy adult volunteers and HIV-1-infected subjects were an asymptomatic and heterogeneous group of individuals with regard to immunologic and virologic markers of HIV-1 disease. The frequency of the CCR5 mutant allele (delta32ccr5) in this population was 0.032; however, no delta32ccr5 homozygote was detected. These results could be related to the intense ethnic admixture of the Brazilian population. There was no correlation between circulating ?-chemokines (MIP-1alpha, RANTES) and viral load in HIV-infected individuals. RANTES concentrations in plasma samples from HIV+ patients carrying the homozygous CCR5 allele (CCR5/CCR5) (28.23 ng/ml) were higher than in the control samples (16.07 ng/ml; P
机译:HIV-1共受体CCR5中的32-BP缺失赋予纯合体中纯合体中HIV-1感染的高度抗性,并在杂合子疾病进展期间对HIV-1进行部分保护。 CCR5,MIP-1Alpha,MIP-1的天然配体?已经证明和咆哮抑制CD4 + T细胞中的HIV复制。在本研究中,我们通过ELISA在献血者(n = 26)和HIV-1感染的个体中,通过PCR和浆液和MIP-1α的浆液和MIP-1α的血浆和MIP-1α的血浆水平(n = 129)。对照组由健康的成人志愿者组成,HIV-1感染受试者是关于HIV-1疾病的免疫学和病毒学标志物的无症状和异质组。该群体中CCR5突变体等级(Delta32ccr5)的频率为0.032;但是,未检测到delta32ccr5 homozygote。这些结果可能与巴西人口的激烈的民族混合有关。循环的循环(MIP-1Alpha,Rantes)和病毒载体之间没有相关性,艾滋病毒感染的个体。 rantes浓度来自携带纯合CCR5等位基因的HIV +患者的血浆样品(CCR5 / CCR5)(28.23 ng / ml)高于对照样品(16.07ng / ml; p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号